Fatty Liver
178
19
23
93
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
23 trials with published results (13%)
Research Maturity
93 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.4%
15 terminated out of 178 trials
86.1%
-0.5% vs benchmark
13%
23 trials in Phase 3/4
25%
23 of 93 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 93 completed trials
Clinical Trials (178)
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
Effects of Resistance-Based Multicomponent Training Incorporating Respiratory Exercise on Diaphragm Thickness, Hepatic Attenuation, and Quality of Life in Healthy Older Men: A Randomized Controlled Trial
Early Tracking of Childhood Health Determinants (ETCHED) Study
Night Hyperglycemia and Fatty Liver in Type 1 Diabetes
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Detecting Liver Fibrosis in Patients At-risk
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
Assessment of Fatty Liver With Thermo-acoustic Device
A Pathophysiological Study of the Postprandial Human Liver (PLS)
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)
Association Between Fatty Liver and Inflammatory Biomarkers
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)
Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
Siemens Biomarker Multi-modality
Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease